SAR of Ligand Binding to a CaVity in HIV gp120
Journal of Medicinal Chemistry, 2007, Vol. 50, No. 20 4907
(7) Wu, L.; Gerard, N. P.; Wyatt, R.; Choe, H.; Parolin, C.; Ruffing,
N.; Borsetti, A.; Cardoso, A. A.; Desjardin, E.; Newman, W.; Gerard,
C.; Sodroski, J. CD4-induced interaction of primary HIV-1 gp120
glycoproteins with the chemokine receptor CCR-5. Nature 1996, 384
(6605), 179-183.
(8) Dimitrov, A. S.; Xiao, X.; Dimitrov, D. S.; Blumenthal, R. Early
intermediates in HIV-1 envelope glycoprotein-mediated fusion trig-
gered by CD4 and co-receptor complexes. J. Biol. Chem. 2001, 276
(32), 30335-30341.
(9) Furuta, R. A.; Wild, C. T.; Weng, Y.; Weiss, C. D. Capture of an
early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol.
1998, 5 (4), 276-279.
(10) Lu, M.; Blacklow, S. C.; Kim, P. S. A trimeric structural domain of
the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 1995, 2
(12), 1075-1082.
(11) Weissenhorn, W.; Dessen, A.; Harrison, S. C.; Skehel, J. J.; Wiley,
D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature
1997, 387 (6631), 426-430.
(12) Chan, D. C.; Fass, D.; Berger, J. M.; Kim, P. S. Core structure of
gp41 from the HIV envelope glycoprotein. Cell 1997, 89 (2), 263-
273.
(13) Kwong, P. D.; Wyatt, R.; Majeed, S.; Robinson, J.; Sweet, R. W.;
Sodroski, J.; Hendrickson, W. A. Structures of HIV-1 gp120 envelope
glycoproteins from laboratory-adapted and primary isolates. Structure
2000, 8 (12), 1329-1339.
(14) Kwong, P. D.; Wyatt, R.; Robinson, J.; Sweet, R. W.; Sodroski, J.;
Hendrickson, W. A. Structure of an HIV gp120 envelope glycoprotein
in complex with the CD4 receptor and a neutralizing human antibody.
Nature 1998, 393 (6686), 648-659.
(15) Huang, C. C.; Tang, M.; Zhang, M. Y.; Majeed, S.; Montabana, E.;
Stanfield, R. L.; Dimitrov, D. S.; Korber, B.; Sodroski, J.; Wilson,
I. A.; Wyatt, R.; Kwong, P. D. Structure of a V3-containing HIV-1
gp120 core. Science 2005, 310 (5750), 1025-1028.
(16) Wyatt, R.; Kwong, P. D.; Desjardins, E.; Sweet, R. W.; Robinson,
J.; Hendrickson, W. A.; Sodroski, J. G. The antigenic structure of
the HIV gp120 envelope glycoprotein. Nature 1998, 393 (6686),
705-711.
(17) Sattentau, Q. J.; Moore, J. P.; Vignaux, F.; Traincard, F.; Poignard,
P. Conformational changes induced in the envelope glycoproteins
of the human and simian immunodeficiency viruses by soluble
receptor binding. J. Virol. 1993, 67 (12), 7383-7393.
(18) Thali, M.; Moore, J. P.; Furman, C.; Charles, M.; Ho, D. D.;
Robinson, J.; Sodroski, J. Characterization of conserved human
immunodeficiency virus type 1 gp120 neutralization epitopes exposed
upon gp120-CD4 binding. J. Virol. 1993, 67 (7), 3978-3988.
(19) Thali, M.; Furman, C.; Ho, D. D.; Robinson, J.; Tilley, S.; Pinter,
A.; Sodroski, J. Discontinuous, conserved neutralization epitopes
overlapping the CD4-binding region of human immunodeficiency
virus type 1 gp120 envelope glycoprotein. J. Virol. 1992, 66 (9),
5635-5641.
(20) Xiang, S. H.; Kwong, P. D.; Gupta, R.; Rizzuto, C. D.; Casper, D.
J.; Wyatt, R.; Wang, L.; Hendrickson, W. A.; Doyle, M. L.; Sodroski,
J. Mutagenic stabilization and/or disruption of a CD4-bound state
reveals distinct conformations of the human immunodeficiency virus
type 1 gp120 envelope glycoprotein. J. Virol. 2002, 76 (19), 9888-
9899.
(21) Chen, B.; Vogan, E. M.; Gong, H.; Skehel, J. J.; Wiley, D. C.;
Harrison, S. C. Structure of an unliganded simian immunodeficiency
virus gp120 core. Nature 2005, 433 (7028), 834-841.
(22) Zhou, T.; Xu, L.; Dey, B.; Hessell, A. J.; Van Ryk, D.; Xiang, S.
H.; Yang, X.; Zhang, M. Y.; Zwick, M. B.; Arthos, J.; Burton, D.
R.; Dimitrov, D. S.; Sodroski, J.; Wyatt, R.; Nabel, G. J.; Kwong, P.
D. Structural definition of a conserved neutralization epitope on
HIV-1 gp120. Nature 2007, 445 (7129), 732-737.
(23) Myszka, D. G.; Sweet, R. W.; Hensley, P.; Brigham-Burke, M.;
Kwong, P. D.; Hendrickson, W. A.; Wyatt, R.; Sodroski, J.; Doyle,
M. L. Energetics of the HIV gp120-CD4 binding reaction. Proc.
Natl. Acad. Sci. U.S.A. 2000, 97 (16), 9026-9031.
(24) Yuan, W.; Bazick, J.; Sodroski, J. Characterization of the multiple
conformational states of free monomeric and trimeric human immu-
nodeficiency virus envelope glycoproteins after fixation by cross-
linker. J. Virol. 2006, 80 (14), 6725-6737.
(27) Guo, Q.; Ho, H. T.; Dicker, I.; Fan, L.; Zhou, N.; Friborg, J.; Wang,
T.; McAuliffe, B. V.; Wang, H. G.; Rose, R. E.; Fang, H.; Scarnati,
H. T.; Langley, D. R.; Meanwell, N. A.; Abraham, R.; Colonno, R.
J.; Lin, P. F. Biochemical and genetic characterizations of a novel
human immunodeficiency virus type 1 inhibitor that blocks gp120-
CD4 interactions. J. Virol. 2003, 77 (19), 10528-10536.
(28) Wang, T.; Zhang, Z.; Wallace, O. B.; Deshpande, M.; Fang, H.; Yang,
Z.; Zadjura, L. M.; Tweedie, D. L.; Huang, S.; Zhao, F.; Ranadive,
S.; Robinson, B. S.; Gong, Y. F.; Ricarrdi, K.; Spicer, T. P.; Deminie,
C.; Rose, R.; Wang, H. G.; Blair, W. S.; Shi, P. Y.; Lin, P. F.;
Colonno, R. J.; Meanwell, N. A. Discovery of 4-benzoyl-1-[(4-
methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpip-
erazine (BMS-378806): a novel HIV-1 attachment inhibitor that
interferes with CD4-gp120 interactions. J. Med. Chem. 2003, 46 (20),
4236-4239.
(29) Ho, H. T.; Fan, L.; Nowicka-Sans, B.; McAuliffe, B.; Li, C. B.;
Yamanaka, G.; Zhou, N.; Fang, H.; Dicker, I.; Dalterio, R.; Gong,
Y. F.; Wang, T.; Yin, Z.; Ueda, Y.; Matiskella, J.; Kadow, J.;
Clapham, P.; Robinson, J.; Colonno, R.; Lin, P. F. Envelope
conformational changes induced by human immunodeficiency virus
type 1 attachment inhibitors prevent CD4 binding and downstream
entry events. J. Virol. 2006, 80 (8), 4017-4025.
(30) Zhao, Q.; Ma, L.; Jiang, S.; Lu, H.; Liu, S.; He, Y.; Strick, N.;
Neamati, N.; Debnath, A. K. Identification of N-phenyl-N′-(2,2,6,6-
tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry
inhibitors that prevent gp120 binding to CD4. Virology 2005, 339
(2), 213-225.
(31) Si, Z.; Madani, N.; Cox, J. M.; Chruma, J. J.; Klein, J. C.; Schon,
A.; Phan, N.; Wang, L.; Biorn, A. C.; Cocklin, S.; Chaiken, I.; Freire,
E.; Smith, A. B., III; Sodroski, J. G. Small-molecule inhibitors of
HIV-1 entry block receptor-induced conformational changes in the
viral envelope glycoproteins. Proc. Natl. Acad. Sci. U.S.A. 2004, 101
(14), 5036-5041.
(32) Madani, N.; Perdigoto, A. L.; Srinivasan, K.; Cox, J. M.; Chruma,
J. J.; LaLonde, J.; Head, M.; Smith, A. B., III; Sodroski, J. G.
Localized changes in the gp120 envelope glycoprotein confer
resistance to human immunodeficiency virus entry inhibitors BMS-
806 and #155. J. Virol. 2004, 78 (7), 3742-3752.
(33) Schon, A.; Madani, N.; Klein, J. C.; Hubicki, A.; Ng, D.; Yang, X.;
Smith, A. B., III; Sodroski, J.; Freire, E. Thermodynamics of binding
of a low-molecular-weight CD4 mimetic to HIV-1 gp120. Biochem-
istry 2006, 45 (36), 10973-10980.
(34) Cochran, A. G. Antagonists of protein-protein interactions. Chem.
Biol. 2000, 7 (4), R85-R94.
(35) Huang, C. C.; Stricher, F.; Martin, L.; Decker, J. M.; Majeed, S.;
Barthe, P.; Hendrickson, W. A.; Robinson, J.; Roumestand, C.;
Sodroski, J.; Wyatt, R.; Shaw, G. M.; Vita, C.; Kwong, P. D.
Scorpion-toxin mimics of CD4 in complex with human immunode-
ficiency virus gp120 crystal structures, molecular mimicry, and
neutralization breadth. Structure 2005, 13 (5), 755-768.
(36) Bohacek, R. S.; McMartin, C. Multiple highly diverse structures
complementary to enzyme binding sites: results of extensive
application of a de novo design method incorporating combinatorial
growth. J. Am. Chem. Soc. 1994, 116 (13), 5560-5571.
(37) Ripka, A. S.; Satyshur, K. A.; Bohacek, R. S.; Rich, D. H. Aspartic
protease inhibitors designed from computer-generated templates bind
as predicted. Org. Lett. 2001, 3 (15), 2309-2312.
(38) Arthos, J.; Deen, K. C.; Chaikin, M. A.; Fornwald, J. A.; Sathe, G.;
Sattentau, Q. J.; Clapham, P. R.; Weiss, R. A.; McDougal, J. S.;
Pietropaolo, C.; Axel, R.; Truneh, A.; Maddon, P. J.; Sweet, R. W.
Identification of the residues in human CD4 critical for the binding
of HIV. Cell 1989, 57 (3), 469-481.
(39) Smith, D. H.; Byrn, R. A.; Marsters, S. A.; Gregory, T.; Groopman,
J. E.; Capon, D. J. Blocking of HIV-1 infectivity by a soluble,
secreted form of the CD4 antigen. Science 1987, 238 (4834), 1704-
1707.
(40) Gadek, T. R. Strategies and methods in the identification of
antagonists of protein-protein interactions. BioTechniques 2003,
Suppl., 21-24.
(41) Carr, R.; Jhoti, H. Structure-based screening of low-affinity com-
pounds. Drug DiscoVery Today 2002, 7 (9), 522-527.
(42) Erlanson, D. A.; Braisted, A. C.; Raphael, D. R.; Randal, M.; Stroud,
R. M.; Gordon, E. M.; Wells, J. A. Site-directed ligand discovery.
Proc. Natl. Acad. Sci. U.S.A. 2000, 97 (17), 9367-9372.
(43) Smith, A. B., III; Savinov, S. N.; Manjappara, U. V.; Chaiken, I. M.
Peptide-small molecule hybrids via orthogonal deprotection-
chemoselective conjugation to cysteine-anchored scaffolds. A model
study. Org. Lett. 2002, 4 (23), 4041-4044.
(44) Martin, L.; Stricher, F.; Misse, D.; Sironi, F.; Pugniere, M.; Barthe,
P.; Prado-Gotor, R.; Freulon, I.; Magne, X.; Roumestand, C.; Menez,
A.; Lusso, P.; Veas, F.; Vita, C. Rational design of a CD4 mimic
that inhibits HIV-1 entry and exposes cryptic neutralization epitopes.
Nat. Biotechnol. 2003, 21 (1), 71-76.
(25) Vermeire, K.; Schols, D. Anti-HIV agents targeting the interaction
of gp120 with the cellular CD4 receptor. Expert Opin. InVest. Drugs
2005, 14 (10), 1199-1212.
(26) Lin, P. F.; Blair, W.; Wang, T.; Spicer, T.; Guo, Q.; Zhou, N.; Gong,
Y. F.; Wang, H. G.; Rose, R.; Yamanaka, G.; Robinson, B.; Li, C.
B.; Fridell, R.; Deminie, C.; Demers, G.; Yang, Z.; Zadjura, L.;
Meanwell, N.; Colonno, R. A small molecule HIV-1 inhibitor that
targets the HIV-1 envelope and inhibits CD4 receptor binding. Proc.
Natl. Acad. Sci. U.S.A. 2003, 100 (19), 11013-11018.